Lung Adenocarcinoma Clinical Trials

121 clinical trials for Lung Adenocarcinoma across international registries, including 34 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors — RECRUITING · PHASE1
• DBC-664 in Adult Patients With Solid Tumors — RECRUITING · PHASE1
• SL-28 for Advanced Solid Tumours — RECRUITING · PHASE1
• Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma — RECRUITING
• Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer — RECRUITING · NA
• Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib — RECRUITING
• Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors — RECRUITING
• Shared Decision Making in Patients With Lung Cancer — RECRUITING
• Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma — RECRUITING · PHASE2
• Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm — RECRUITING · NA
• Pathogenic Variants in Genes Associated With Lung Adenocarcinoma — RECRUITING
• Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases — RECRUITING · PHASE3
• Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma — RECRUITING · NA
• Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors — RECRUITING · PHASE1
• Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients — RECRUITING
• Engagement of Veterans With Lung Cancer — RECRUITING · NA
• Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer — RECRUITING · NA
• Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma — RECRUITING · PHASE1
• Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma — RECRUITING · PHASE3
• An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer — RECRUITING · PHASE1
• Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection — RECRUITING
• Lymph Node Pathologic Grading Strategy — RECRUITING
• Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma — RECRUITING
• WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma — RECRUITING
• Segmentectomy for Solid-dominant Lung Cancer — RECRUITING · PHASE3
• Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) — RECRUITING · PHASE3
• Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK — RECRUITING · PHASE2
• Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers — RECRUITING
• Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) — RECRUITING · PHASE3
• Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic — RECRUITING · NA
• Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) — RECRUITING · PHASE3
• Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm — RECRUITING
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy — RECRUITING
• Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative — SUSPENDED · PHASE2
• Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE1
• Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE2
• Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer — COMPLETED · PHASE2
• Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer — NOT_YET_RECRUITING · PHASE1
• CLINICAL STUDY TO IDENTIFY BIOMARKERS FOR TUMOR SPREAD THROUGH AIR SPACES STATUS — NOT_YET_RECRUITING
• Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC — NOT_YET_RECRUITING · PHASE2
• Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC — NOT_YET_RECRUITING
• Evaluation of Different Sizes of Left-Sided Double-Lumen Tubes for Thoracic Surgery in a Tertiary Level Teaching Hospital — NOT_YET_RECRUITING · NA
• ADH1B and ALDH Gene Variants and Lung Cancer Risk — NOT_YET_RECRUITING
• Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT — NOT_YET_RECRUITING · PHASE3
• Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer — COMPLETED · PHASE1
• DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma — COMPLETED

Refine this search